Table 2 Baseline characteristics of the studied patients according to steroid therapy responsiveness
Parameter | Steroid responders | Steroid non-responders | p |
|---|---|---|---|
N = 45(64.3%) | N = 25(35.7%) | ||
Age(years) (means ± SD) | 47.711 ± 11.885 | 45.04 ± 9.104 | 0.333 |
Male gender n (%) | 20 (44.4%) | 9 (36%) | 0.492 |
BMI(kg/m2) (means ± SD) | 30.044 ± 3.275 | 30.36 ± 2.856 | 0.688 |
CSS | 8.3 ± 1.4 | 7.9 ± 1.6 | 0.394 |
FVC % pred. (means ± SD) | 96.295 ± 2.12 | 94.80 ± 3.149 | 0.06 |
FEV1, % pred. (means ± SD) | 83.533 ± 2.801 | 91.00 ± 3.606 | < 0.001 |
FEV1/FVC (means ± SD) | 85.556 ± 2.312 | 95.00 ± 1.607 | < 0.001 |
FeNO (ppb) (means ± SD) | 48.333 ± 11.576 | 20.16 ± 8.452 | < 0.001 |
Sputum eosinophils % (means ± SD) | 9.062 ± 4.496 | 1.780 ± 0.847 | < 0.001 |